These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3111000)

  • 1. Aspirin decreases fibrinolytic potential during venous occlusion, but not during acute physical activity.
    Keber I; Jereb M; Keber D
    Thromb Res; 1987 Apr; 46(2):205-12. PubMed ID: 3111000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaustion of arm fibrinolytic potential after repeated venous occlusions and local exercise.
    Keber D; Stegnar M
    Thromb Res; 1982 Dec; 28(6):693-704. PubMed ID: 6891973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and venous occlusion: effects on blood fibrinolytic activity and tissue-type plasminogen activator levels.
    Hammouda MW; Moroz LA
    Thromb Res; 1986 Apr; 42(1):73-82. PubMed ID: 3085277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusion.
    Bounameaux H; Gresele P; Hanss M; De Cock F; Vermylen J; Collen D
    Thromb Res; 1985 Oct; 40(2):161-70. PubMed ID: 3934784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids.
    Iacoviello L; Amore C; De Curtis A; Tacconi MT; de Gaetano G; Cerletti C; Donati MB
    Arterioscler Thromb; 1992 Oct; 12(10):1191-7. PubMed ID: 1390591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion.
    Keber D; Stegnar M; Kluft C
    Thromb Haemost; 1990 Feb; 63(1):72-5. PubMed ID: 2111049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of aspirin on fibrinolysis is reversed by iloprost, a prostacyclin analogue.
    Bertelé V; Mussoni L; Pintucci G; del Rosso G; Romano G; de Gaetano G; Libretti A
    Thromb Haemost; 1989 Apr; 61(2):286-8. PubMed ID: 2473539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of retinoids on fibrinolysis before and after venous occlusion in healthy humans.
    Bounameaux H; Reber G; Bounameaux Y
    Thromb Res; 1988 Apr; 50(1):175-9. PubMed ID: 3400079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aspirin on the fibrinolytic response in perfused rat hindquarters.
    Iacoviello L; De Curtis A; Amore C; D'Adamo MC; Buczko W; de Gaetano G; Donati MB
    Eur J Pharmacol; 1992 Dec; 229(1):39-44. PubMed ID: 1473562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin is required for t-PA release after venous occlusion.
    Iacoviello L; De Curtis A; D'Adamo MC; Amore C; Buczko W; De Gaetano G; Donati MB
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H429-34. PubMed ID: 7511345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease.
    Poredos P; Stegnar M; Gacnik A
    Vasa; 1999 May; 28(2):106-11. PubMed ID: 10409921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic system in adolescents: response to venous occlusion stress tests.
    Monagle P; Chan AK; Albisetti M; Vegh P; Andrew M; Mitchell L
    Pediatr Res; 2003 Feb; 53(2):333-7. PubMed ID: 12538795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin.
    Stegnar M; Pentek M
    Thromb Res; 1993 Jan; 69(1):81-92. PubMed ID: 8465277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of beta-adrenergic blockade upon baseline blood coagulation and fibrinolytic activity and upon the responses to venous occlusion.
    Butler MJ; Smith M; Irving MH; Gordon YB; Ratky SM; Rivers JW; Hawkey C
    Thromb Diath Haemorrh; 1975 Sep; 34(1):169-80. PubMed ID: 1188710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose aspirin does not prevent fibrinolytic response to venous occlusion.
    de Gaetano G; Carriero MR; Cerletti C; Mussoni L
    Biochem Pharmacol; 1986 Sep; 35(18):3147-50. PubMed ID: 3755907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
    Kubicka A; Libura M; Sacha T; Swadźba J; Undas A; Wandzilak M
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):116-9. PubMed ID: 8361905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of remote ischaemic conditioning on coagulation and fibrinolysis.
    Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM
    Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.